Skip to main content

Table 1 Baseline characteristics of CAD and control groups

From: A genetic variant c.553G > T (rs2075291) in the apolipoprotein A5 gene is associated with altered triglycerides levels in coronary artery disease (CAD) patients with lipid lowering drug

  CAD (354) Control (377) P-value
Age (years) 58.52 ± 11.10 37.3 ± 14.7 0.000
Gender (Male/ Female) 235/119 246/131 0.9009
Hypertension (n) 1.31 ± 0.51 1.78 ± 0.41 0.001
Glucose (mmol/ l) 1.39 ± 0.53 1.82 ± 0.38 0.000
HDL-C (mmol/ l) 1.37 ± 0.56 1.46 ± 0.63 0.103
LDL-C (mmol/ l) 1.65 ± 0.96 1.55 ± 0.80 0.191
Chol-C (mmol/ l) 1.17 ± 0.46 1.10 ± 0.36 0.041
TG-C (mmol/ l) 1.51 ± 0.82 1.16 ± 0.46 0.000